TriSalus Life Sciences (TLSI) Operating Leases (2022 - 2025)
Historic Operating Leases for TriSalus Life Sciences (TLSI) over the last 4 years, with Q3 2025 value amounting to $1.2 million.
- TriSalus Life Sciences' Operating Leases fell 1826.03% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 1826.03%. This contributed to the annual value of $1.3 million for FY2024, which is 683.28% up from last year.
- According to the latest figures from Q3 2025, TriSalus Life Sciences' Operating Leases is $1.2 million, which was down 1826.03% from $1.3 million recorded in Q2 2025.
- TriSalus Life Sciences' 5-year Operating Leases high stood at $1.6 million for Q4 2022, and its period low was $1.2 million during Q2 2024.
- For the 4-year period, TriSalus Life Sciences' Operating Leases averaged around $1.3 million, with its median value being $1.3 million (2025).
- In the last 5 years, TriSalus Life Sciences' Operating Leases plummeted by 2190.83% in 2023 and then skyrocketed by 1426.4% in 2024.
- Over the past 4 years, TriSalus Life Sciences' Operating Leases (Quarter) stood at $1.6 million in 2022, then dropped by 21.91% to $1.2 million in 2023, then rose by 6.83% to $1.3 million in 2024, then dropped by 7.37% to $1.2 million in 2025.
- Its Operating Leases stands at $1.2 million for Q3 2025, versus $1.3 million for Q2 2025 and $1.3 million for Q1 2025.